Corcept Therapeutics (CORT) Short Interest Ratio & Short Volume → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free CORT Stock Alerts $23.37 +0.57 (+2.50%) (As of 04/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corcept Therapeutics Short Interest DataCurrent Short Volume21,120,000 sharesPrevious Short Volume21,330,000 sharesChange Vs. Previous Month-0.98%Dollar Volume Sold Short$488.93 millionShort Interest Ratio / Days to Cover17.5Last Record DateApril 15, 2024Outstanding Shares104,080,000 sharesFloat Size89,190,000 sharesShort Percent of Float23.68%Today's Trading Volume556,258 sharesAverage Trading Volume1,454,465 sharesToday's Volume Vs. Average38% Short Selling Corcept Therapeutics ? Sign up to receive the latest short interest report for Corcept Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCORT Short Interest Over TimeCORT Days to Cover Over TimeCORT Percentage of Float Shorted Over Time Ad Unstoppable ProsperityCharles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET Corcept Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202421,120,000 shares $488.93 million -1.0%23.7%17.5 $23.15 3/31/202421,330,000 shares $537.30 million +5.5%23.9%15 $25.19 3/15/202420,220,000 shares $469.71 million +1.8%22.7%13 $23.23 2/29/202419,860,000 shares $466.71 million +1.1%22.3%13.1 $23.50 2/15/202419,640,000 shares $480.39 million +1.7%22.0%13.4 $24.46 1/31/202419,320,000 shares $407.65 million +23.3%22.0%14.4 $21.10 Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202415,670,000 shares $363.54 million +1.8%17.8%13.2 $23.20 12/31/202315,390,000 shares $499.87 million +0.9%17.5%17 $32.48 12/15/202315,260,000 shares $453.99 million -0.8%17.4%19.6 $29.75 11/30/202315,380,000 shares $391.73 million +0.7%17.5%21.2 $25.47 11/15/202315,270,000 shares $387.55 million +8.1%17.4%20.6 $25.38 10/31/202314,120,000 shares $396.49 million -5.6%16.1%19.4 $28.08 10/15/202314,960,000 shares $412.30 million -0.1%17.1%20 $27.56 9/30/202314,970,000 shares $407.86 million +3.4%17.1%20.8 $27.25 9/15/202314,480,000 shares $484.65 million -2.2%16.6%24.1 $33.47 8/31/202314,800,000 shares $484.40 million -0.5%17.0%23.7 $32.73 8/15/202314,870,000 shares $460.38 million -1.3%17.1%23.9 $30.96 7/31/202315,070,000 shares $383.98 million -4.2%17.3%23.9 $25.48 7/15/202315,730,000 shares $358.96 million -1.1%18.2%27.3 $22.82 6/30/202315,910,000 shares $354.00 million -5.1%18.4%25.2 $22.25 6/15/202316,770,000 shares $388.90 million +0.2%19.2%21.6 $23.19 5/31/202316,730,000 shares $392.99 million -2.3%19.2%20.9 $23.49 5/15/202317,130,000 shares $412.15 million No Change19.6%19.2 $24.06 10/31/202217,050,000 shares $487.63 million -0.8%18.3%30.1 $28.60 10/15/202217,190,000 shares $467.91 million -0.8%18.6%30.8 $27.22 9/30/202217,330,000 shares $444.34 million +1.5%18.7%29.7 $25.64 9/15/202217,070,000 shares $431.87 million -1.6%18.5%26.7 $25.30 8/31/202217,350,000 shares $447.98 million -1.0%18.8%27 $25.82 8/15/202217,530,000 shares $492.07 million -2.2%19.0%25.6 $28.07 7/31/202217,930,000 shares $513.87 million +1.1%19.0%22.4 $28.66 7/15/202217,730,000 shares $482.97 million -1.8%18.8%21.5 $27.24 6/30/202218,060,000 shares $429.47 million -0.6%17.5%20.5 $23.78 6/15/202218,170,000 shares $383.39 million -5.6%17.6%19.8 $21.10 5/31/202219,240,000 shares $400.96 million -5.2%20.4%20.1 $20.84 5/15/202220,300,000 shares $384.48 million +12.0%21.5%20.6 $18.94 4/30/202218,130,000 shares $389.98 million +9.5%19.2%18.7 $21.51 4/15/202216,560,000 shares $405.55 million +2.8%17.6%17.5 $24.49 3/31/202216,110,000 shares $362.80 million -2.8%N/A18 $22.52 3/15/202216,570,000 shares $397.68 million +2.3%17.6%16.7 $24.00 2/28/202216,200,000 shares $361.10 million -0.9%17.1%9.6 $22.29Charles Payne’s Gift to Stock Investors (Ad)Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET CORT Short Interest - Frequently Asked Questions What is Corcept Therapeutics' current short interest? Short interest is the volume of Corcept Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 21,120,000 shares of CORT short. 23.68% of Corcept Therapeutics' shares are currently sold short. Learn More on Corcept Therapeutics' current short interest. What is a good short interest ratio for Corcept Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CORT shares currently have a short interest ratio of 18.0. Learn More on Corcept Therapeutics's short interest ratio. Which institutional investors are shorting Corcept Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corcept Therapeutics: Simplex Trading LLC, and Kynam Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corcept Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.68% of Corcept Therapeutics' floating shares are currently sold short. Is Corcept Therapeutics' short interest increasing or decreasing? Corcept Therapeutics saw a decline in short interest in April. As of April 15th, there was short interest totaling 21,120,000 shares, a decline of 1.0% from the previous total of 21,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corcept Therapeutics' float size? Corcept Therapeutics currently has issued a total of 104,080,000 shares. Some of Corcept Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corcept Therapeutics currently has a public float of 89,190,000 shares. How does Corcept Therapeutics' short interest compare to its competitors? 23.68% of Corcept Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corcept Therapeutics: Supernus Pharmaceuticals, Inc. (8.93%), Taro Pharmaceutical Industries Ltd. (0.58%), Axsome Therapeutics, Inc. (16.36%), Pacira BioSciences, Inc. (7.42%), Xencor, Inc. (10.09%), OPKO Health, Inc. (23.81%), Perrigo Company plc (2.88%), ADC Therapeutics SA (1.60%), Atea Pharmaceuticals, Inc. (2.37%), Jazz Pharmaceuticals plc (6.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Corcept Therapeutics stock? Short selling CORT is an investing strategy that aims to generate trading profit from Corcept Therapeutics as its price is falling. CORT shares are trading up $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corcept Therapeutics? A short squeeze for Corcept Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CORT, which in turn drives the price of the stock up even further. How often is Corcept Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Supernus Pharmaceuticals Short Squeeze Taro Pharmaceutical Industries Short Squeeze Axsome Therapeutics Short Squeeze Pacira BioSciences Short Squeeze Xencor Short Squeeze OPKO Health Short Squeeze Perrigo Short Squeeze ADC Therapeutics Short Squeeze Atea Pharmaceuticals Short Squeeze Jazz Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORT) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media4 coins to be the “Next Bitcoin”True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press